Harsh Shah 3/23/26 Harsh Shah 3/23/26

Real-Time Quality Record Analysis Against Regulatory Standards

Quality records are analyzed through periodic audits that sample a fraction of documents months after creation. AI-powered real-time analysis evaluates every batch record, deviation investigation, CAPA, and OOS report against FDA, ICH, and EU GMP requirements the moment each record is finalized — replacing sampling with complete regulatory coverage.

Harsh Shah 3/23/26 Harsh Shah 3/23/26

Detecting Systemic Compliance Issues in Pharmaceutical Manufacturing

"Systemic" is the word that separates a 483 observation from a warning letter. AI detects cross-event patterns that QMS platforms and periodic audits miss: recurring investigation inadequacies, CAPA effectiveness failures, cross-site compliance gaps, and progressive documentation quality degradation — before FDA investigators find them.

Harsh Shah 3/4/26 Harsh Shah 3/4/26

How AI Enables Continuous GMP and GCP Compliance Monitoring

GMP and GCP generate the majority of pharmaceutical compliance findings, yet both are monitored through periodic audits with months-long blind spots. AI enables continuous monitoring of both domains simultaneously with cross-domain signal detection.

Harsh Shah 3/4/26 Harsh Shah 3/4/26

Benefits of Integrating AI into Quality Management Systems for Biotech

Biotech firms face enterprise regulatory requirements with startup resources. Integrating AI into quality management delivers regulatory content analysis that QMS platforms cannot provide, immediate compliance capability without enterprise infrastructure, cross-domain visibility, dramatic cost reduction, and complete workflow management.

Harsh Shah 2/12/26 Harsh Shah 2/12/26

AI-Powered Submission Readiness: How Regulatory Intelligence Prevents Complete Response Letters — Clinplex AI

Complete Response Letters trace to documentation deficiencies that existed months before filing. AI-powered submission readiness scoring evaluates eCTD Modules 1–5 against ICH M4 content requirements, verifies cross-module consistency, and quantifies NDA/BLA readiness — identifying gaps that trigger CRLs before the submission is filed.

Harsh Shah 2/12/26 Harsh Shah 2/12/26

How AI Is Transforming GCP Compliance and Clinical Trial Regulatory Intelligence

Clinical trial compliance generates thousands of regulatory documents across sites and jurisdictions. AI regulatory intelligence evaluates every clinical document against ICH E6(R2), 21 CFR 312, and FDA guidance — continuously, not just during periodic GCP audits. Cross-domain connections link clinical findings to manufacturing, submission, and pharmacovigilance implications.